Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
Decitabine and FR901228 in Treating Patients With Advanced Lung Cancer, Esophageal Cancer, Pleural Mesothelioma, or Lung Metastases
This study is currently recruiting participants.
Study NCT00041158. Last updated on November 1, 2008. Information provided by National Cancer Institute (NCI)
Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1
Conditions listed in this trial
Esophageal Cancer
Lung Cancer
Malignant Mesothelioma
Metastatic Cancer
2
Additional conditions recognized in this trial
Esophageal Diseases
Esophageal Neoplasms
Lung Neoplasms
Mesothelioma
Neoplasm Metastasis
3
More general conditions related to this trial
Adenoma
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Head and Neck Neoplasms
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplasms, Mesothelial
Neoplastic Processes
Pathologic Processes
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
4
Interventions listed in this trial
celecoxib
decitabine
romidepsin
5
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
6
Sponsors listed in this trial
NCI - Center for Cancer Research-Medical Oncology
National Cancer Institute (NCI)
U.S. National Library of Medicine
,
Contact Help Desk
U.S. National Institutes of Health
,
U.S. Department of Health & Human Services
,
USA.gov
,
Copyright
,
Privacy
,
Accessibility
,
Freedom of Information Act
Links to all studies - primarily for crawlers